Deep Venous Thrombosis: Clinical Trials

89 trials for Deep Venous Thrombosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 20 unknown, 10 terminated, 4 recruiting. 24 Not applicable, 18 Phase 3, 12 Phase 4, 9 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable24Completed 11, Unknown 8, Recruiting 3, Withdrawn 2
Phase 318Completed 9, Terminated 5, Unknown 3, Recruiting 1
Phase 412Completed 4, Unknown 3, Terminated 2, Withdrawn 2, Not yet recruiting 1
Phase 29Completed 5, Terminated 2, Recruiting 1, Unknown 1
Phase 14Completed 2, Active not recruiting 1, Terminated 1
Early Phase 12Completed 2

Follow Deep Venous Thrombosis: new trials by email Literature Review of Deep Venous Thrombosis trials Research Report on Deep Venous Thrombosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease
Interstitial Lung Disease, Venous Thromboembolism
Not yet recruitingSohag University1002026-09-012026-09-22
Bedside Bike Early Mobilization Program for Inpatients
Bedside Bike - Immobility Syndrome, Deep Venous Thrombosis
Not applicableWithdrawnIndiana University2026-07-052026-08-24
Second Line Endovascular Treatment in Acute DVT
Thrombolysis/Thrombectomy - Deep Venous Thrombosis
Phase 4Not yet recruitingRush University Medical Center1002026-04-012026-01-28
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
MSK-ACCESS, ctDNA/VTE Risk Score: - Venous Thromboembolism, Deep Venous Thrombosis
Not applicableRecruitingMemorial Sloan Kettering Cancer Center2592026-01-302026-05-05
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
The multifaceted interventions, Routine VTE prophylaxis - Venous Thromboembolic Disease, Pulmonary Embolism
Not applicableRecruitingChina-Japan Friendship Hospital58002025-08-012025-09-17
The Protrieve PROTECTOR Study
Percutaneous mechanical thrombectomy (PMT) - Venous Thromboembolism, Deep Venous Thrombosis
Not applicableCompletedInari Medical662025-03-052026-10-05
Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery
Direct Oral Anticoagulant., Low Molecular Weight Heparine - Deep Venous Thrombosis
Phase 1Active not recruitingCairo University1002024-03-252025-08-26
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc. - Venous Thromboembolism, Deep Venous Thrombosis
Not applicableRecruitingInari Medical3002023-01-062026-09-09
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
Abelacimab, Dalteparin - Venous Thromboembolism, Deep Venous Thrombosis
Phase 3TerminatedAnthos Therapeutics, Inc.4172022-09-272026-04-17
Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
Rivaroxaban 10 MG - Deep Venous Thrombosis, Colonic Cancer
Phase 4UnknownHospital do Servidor Publico Estadual682022-06-012022-03-31
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Enoxaparin - Deep Venous Thrombosis
Phase 2 / Phase 3RecruitingYale University2582022-05-112026-06-08
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Abelacimab, Apixaban - Venous Thromboembolism, Deep Venous Thrombosis
Phase 3TerminatedAnthos Therapeutics, Inc.11502022-05-052026-02-23
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after discharge, Routine VTE prophylaxis in hospital - Venous Thromboembolic Disease, Pulmonary Embolism
Not applicableUnknownChina-Japan Friendship Hospital32002021-12-012021-08-03
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
Receipt of enoxaparin, Placebo - Venous Thromboembolism, Bleeding as Surgical Complication (Treatment)
Phase 4WithdrawnUniversity of Utah2021-07-012021-10-08
Radial, Sequential Compression Device Deep Venous Thrombosis Detection Study
Cirvo Compression device - Deep Venous Thrombosis
Not applicableWithdrawnStanford University2021-01-082021-01-12
FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
Blood draw (Visit 1), Blood draw (Visits 2 and 3) - Deep Venous Thrombosis, Pulmonary Embolism
Active not recruitingUniversity of Texas Southwestern Medical Center1152020-12-222026-06-08
Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology
Deep Venous Thrombosis
CompletedUniversity Hospital, Strasbourg, France302020-06-232021-10-08
Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis
Catheter directed thrombolysis plus anticoagulation, Anticoagulation - Deep Venous Thrombosis, Post Thrombotic Syndrome
Phase 4WithdrawnUniversity of Toledo Health Science Campus2019-12-192021-09-09
Screening for Cancer in Patients With Unprovoked VTE
Fludeoxyglucose 18F - Venous Thromboembolic Disease, Respiratory Disease
Phase 4UnknownFundación Pública Andaluza para la gestión de la Investigación en Sevilla6502019-10-232021-12-09
Clinical Investigation of a Novel Approach for the Prevention of Deep Venous Thrombosis After Total Knee Replacement
active ankle pumping with a regular watch alarm, intermittent pneumatic compression - Deep Venous Thrombosis
Not applicableCompletedShow Chwan Memorial Hospital902019-10-172021-07-27

Showing 20 of 89. Sign in to see all of them.

Narrower conditions

Venous Thrombosis (89)  ·  Pulmonary Embolism (34)  ·  Venous Thromboembolism (26)  ·  Thrombosis (8)  ·  Postthrombotic Syndrome (7)  ·  Atrial Fibrillation (6)  ·  Critical Illness (4)  ·  Hemorrhage (2)  ·  Neoplasms (2)  ·  Postphlebitic Syndrome (2)  ·  Stroke (2)  ·  Thromboembolism (2)  ·  Varicose Ulcer (2)  ·  Acute Kidney Injury (1)  ·  Antiphospholipid Syndrome (1)

Broader conditions

Cardiovascular Diseases (89)  ·  Embolism and Thrombosis (89)  ·  Vascular Diseases (89)  ·  Thrombosis (81)  ·  Respiratory Tract Diseases (36)  ·  Lung Diseases (35)  ·  Embolism (34)  ·  Thromboembolism (26)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Pathologic Processes (14)  ·  Heart Diseases (7)  ·  Venous Insufficiency (7)  ·  Arrhythmias, Cardiac (6)  ·  Disease Attributes (5)  ·  Neoplasms by Site (5)

Interventions

Enoxaparin (10)  ·  Warfarin (6)  ·  Heparin, Low-Molecular-Weight (5)  ·  Dalteparin (4)  ·  Rivaroxaban (4)  ·  apixaban (4)  ·  Heparin (3)  ·  Nadroparin (3)  ·  Blood Specimen Collection (2)  ·  Intermittent Pneumatic Compression Devices (2)  ·  MAA868 (2)  ·  Tinzaparin (2)  ·  abelacimab (2)  ·  Acetaminophen (1)  ·  Aspirin (1)

Sponsors

University of Utah (6)  ·  China-Japan Friendship Hospital (3)  ·  Johns Hopkins University (3)  ·  Karolinska University Hospital (3)  ·  Anthos Therapeutics, Inc. (2)  ·  Diagnostica Stago (2)  ·  Hamilton Health Sciences Corporation (2)  ·  Hospital do Servidor Publico Estadual (2)  ·  Inari Medical (2)  ·  Sir Mortimer B. Davis - Jewish General Hospital (2)  ·  Suzanne C. Cannegieter, MD PhD (2)  ·  University Of Perugia (2)  ·  Yale University (2)  ·  Aalborg University Hospital (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Countries

United States (41)  ·  Canada (12)  ·  France (11)  ·  Italy (9)  ·  China (8)  ·  Netherlands (7)  ·  Australia (6)  ·  Germany (6)  ·  Spain (6)  ·  Austria (5)  ·  Czechia (5)  ·  Norway (5)  ·  Sweden (5)  ·  Brazil (4)  ·  Denmark (4)

Top investigators

Christopher Puccini, MD (4)  ·  Christopher Pannucci, MD MS (2)  ·  Deborah J Cook, MD (2)  ·  Suzanne C Cannegieter, PhD, MD (2)  ·  Zhenguo Zhai, Doctor (2)  ·  Adam Schlifke (1)  ·  Agnes Y Lee, MD (1)  ·  Alexander G Turpie, MB (1)  ·  Ayesha Zia, MD, MSCS (1)  ·  Babar Khan, MD (1)  ·  Benedicte Laursen, MD, DMSc (1)  ·  Bernd Poetzsch, Professor (1)  ·  Bryan Meyers, MD (1)  ·  Bulent Arslan, MD (1)

Results publications

PMID 33086312, PMID 27959702, PMID 29452956, PMID 29649055, PMID 11028492, PMID 12217281, PMID 16310609, PMID 19017588, PMID 19224134, PMID 20088937, PMID 20946157, PMID 21417952, PMID 21482348, PMID 21794899, PMID 21932952, PMID 22041951, PMID 22172244, PMID 22277690, PMID 22621626, PMID 23078631, PMID 23089679, PMID 23164766, PMID 23788287, PMID 23871290, PMID 23942857, PMID 24315521, PMID 24638843, PMID 24726205, PMID 24768093, PMID 25047081, PMID 25183442, PMID 25246013, PMID 25528663, PMID 25903529, PMID 26356708, PMID 26686257, PMID 26853645, PMID 26917821, PMID 26921148, PMID 26992609, PMID 27401184, PMID 27488365, PMID 27488380, PMID 27900179, PMID 28085911, PMID 28550192, PMID 29211671, PMID 29264930, PMID 29544550, PMID 29608533

NIH funding

2005 (1), 2018 (1), 2023 (1), I50HX002263 (1), R01HD106326 (1), R01HL137913 (1), R21HD089131 (1)